Search the Newsreel

Euroseas Ltd. (ESEA) Q2 Earnings and Revenues Surpass Estimates

Euroseas Ltd. (ESEA) reported strong Q2 2026 earnings, surpassing Zacks Consensus Estimates for both earnings per share ($4.7 vs. $4.47 expected) and revenues ($58.08 million vs. $57.99 million expected). The company's shares have risen 36.4% year-to-date, outperforming the S&P 500. Investors are now looking …

EuroDry (NASDAQ:EDRY) Insider Symeon Pariaros Sells 1,900 Shares

EuroDry insider Symeon Pariaros sold 1,900 shares of the company's stock for $75,962, reducing his ownership by 20.71%. The company recently reported strong quarterly earnings, significantly beating analyst estimates, and its stock is trading near its 52-week high. Despite a "Moderate Buy" consensus rating, …

Is NeuroOne Medical Technologies Corp (NMTC) Positioned for Grow

Euroseas earnings beat by $0.61, revenue fell short of estimates

NeuroOne Medical Technologies (NASDAQ: NMTC) posts larger loss and flags going concern risk

NeuroOne Medical Technologies (NMTC) reported a deeper net loss of $2.01 million for Q3 2026 and $5.83 million for the nine months ended June 30, 2026, significantly larger than the previous year. The company's cash and cash equivalents dwindled to $2.05 million, leading management …

Form 8K Neuroone Medical Technologies Corp For: 13 August By Investing.com

This article announces that Neuroone Medical Technologies Corp filed a Form 8K on August 13. It includes the company's stock symbol (NMTC) and its current performance. The content primarily serves as a placeholder for the filing and does not provide further details about the …

NeuroOne posts Q3 FY2026 revenue up 16% to $2.0M; gross margin expands to 59.9%

NeuroOne (NMTC) reported a 16% increase in Q3 FY2026 product revenue to $1.97 million, with product gross margin expanding to 59.9%. Despite a net loss of $2.01 million, the company secured $2.7 million in new product orders and achieved ISO 13485:2016 certification. Significant progress …

NeuroOne Medical Technologies Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2026

Euroseas Ltd. Reports Results for the Quarter Ended June 30, 2026 and Declares Quarterly Common Stock Dividend

Euroseas Ltd. announced strong financial results for the second quarter and first half of 2026, with significant net revenues and earnings per share, driven by high charter rates and low drydocking expenses. The company also declared a quarterly dividend of $0.80 per share and …

UBS verlaagt Coca-Cola Europacific Partners ondanks hogere Q2-omzet en volumes

Deutsche Bank Adjusts Neurocrine Biosciences PT to $165 From $190, Maintains Hold Rating

Deutsche Bank has adjusted its price target for Neurocrine Biosciences (NBIX) to $165, down from $190, while maintaining a Hold rating on the stock. This adjustment comes amidst recent news including positive Phase 4 study results for Ingrezza capsules and the initiation of a …

NeuroOne(R) Reports Fiscal Q3 2026 Financial Results, Revenues Increase 16% YoY to $2.0 Million; Gross Margins Expand to 59.9%

NeuroOne Medical Technologies Corporation reported strong fiscal Q3 2026 financial results, with product revenue increasing 16% year-over-year to $2.0 million and gross margins expanding to 59.9%. The company also announced $2.7 million in new product orders, received ISO 13485 Certification for international expansion, and …

Stoneweg Europe Stapled Trust, Sponsor Explore Structural Changes to Boost Long-Term Value

UBS verlaagt rating Coca-Cola Europacific Partners wegens waardering

UBS downgrades Coca-Cola Europacific Partners stock rating on valuation By Investing.com

Neuropace Inc (NPCE) Earnings Forecast: Future EPS & Revenue Growth Estimates

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Given Consensus Rating of "Moderate Buy" by Brokerages

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) has received a consensus "Moderate Buy" rating from twenty-four brokerages, with an average 12-month price target of $201.50. The company's stock opened at $156.49, has a market capitalization of $15.91 billion, and has seen significant insider selling totaling over $61 …

Euro India Fresh Foods standalone net profit rises 124.24% in the June 2026 quarter

EURO เตรียมจัด Earnings Call อัปเดตงบ Q2-แผนธุรกิจครึ่งปีหลัง 17 ส.ค.นี้

Stoneweg Europe Stapled Trust evaluates management internalisation, posts 1.4% rise in H1 DPS to 0.06642 euro

Stoneweg Europe Stapled Trust's H1 Distributable Income Flat at EUR37 Million

NeuroPace (NPCE) Stock Price Faces Flat Revenue And Lingering Losses

What's Going On With Euro Sun Mining Inc Stock Wednesday?

Alto Neuroscience Q2 EPS beats estimates; completes $100M financing

Alto Neuroscience (NYSE: ANRO) reported a Q2 2026 EPS of $(0.65), exceeding analyst estimates of $(0.73). The company also completed a $100 million financing round in July 2026, boosting its pro forma cash position to approximately $338 million, which is expected to fund operations …

ClearPoint Neuro (CLPT): MAK Capital group discloses 7.8% ownership in 13G/A

MAK Capital Fund LP, MAK Capital One L.L.C., and Michael A. Kaufman have filed a Schedule 13G/A, disclosing a collective beneficial ownership of 2,375,861 shares of ClearPoint Neuro, Inc. (CLPT) common stock. This represents 7.8% of the company's outstanding shares as of June 30, …

Alto Neuroscience (ANRO) boosts cash to $243.7M as R&D spend surges

Alto Neuroscience (ANRO) reported a net loss of $27.6 million for Q2 2026, widening from the previous year, primarily due to increased R&D expenses which surged to $22.1 million. Despite the loss, the company significantly strengthened its balance sheet, increasing cash and cash equivalents …

EuroDry (NASDAQ:EDRY) Director Sells 500 Shares

EuroDry Director Aristeidis Pittas sold 500 shares of the company's stock for $18,900, reducing his holdings by 0.65%. This sale occurred shortly after EuroDry announced strong quarterly EPS of $2.44, significantly beating estimates, though revenue slightly missed expectations. The stock is trading near its …

EuroSports Global Limited Reports Earnings Results for the First Quarter Ended June 30, 2026

Minerva Neurosciences (NERV) elevates Anthony Aliquo to chief accounting officer role

Minerva Neurosciences (NERV) has promoted Anthony Aliquo to Chief Accounting Officer and principal accounting officer, effective August 10, 2026. This move includes an increase in his annual base salary to $296,696 and a performance bonus target of 35%. Frederick Ahlholm remains the Chief Financial …

NeuroPace Q2 Earnings Call Highlights

NeuroPace reported strong Q2 revenue growth driven by its RNS System for adult focal epilepsy, leading to a raised full-year revenue and adjusted EBITDA outlook. The company is also engaging with the FDA regarding expanding the RNS System's indication to idiopathic generalized epilepsy (IGE), …

Why Neurocrine Biosciences (NBIX) Stock Is Down Today

Neurocrine Biosciences (NBIX) stock is down 3.1% today, likely due to investor profit-taking and a reset of expectations following its late-July earnings release. While the company reported strong revenue growth and increased INGREZZA sales guidance, it also raised spending outlooks and highlighted the balance-sheet …

EuroDry (EDRY) corporate secretary sells 400 shares and holds 850 after trade

EuroDry Ltd.'s Corporate Secretary, Stefania Karmiri, reported the sale of 400 shares of common stock on August 11, 2026, at $38.50 per share. Following this transaction, she directly holds 850 shares of the company's common stock. The transaction was classified as an open market …

EuroHoldings Q2 net profit rises 423% to $4.3 million

What's Going On With Neurocrine Biosciences Stock On Wednesday?

Neurocrine Biosciences stock experienced a dip after reports emerged of deaths and severe complications potentially linked to its drug Vykat XR, used for Prader-Willi syndrome. The FDA's adverse event data revealed seven deaths and over 100 serious events, primarily involving edema, respiratory, and cardiac …

Stoneweg Europe Stapled Trust refreshes board to bolster governance and succession

Euronet Worldwide (EEFT): Bank of Montreal group discloses 5.81% ownership stake

Bank of Montreal and its related entities have disclosed a passive ownership stake of 5.81% in Euronet Worldwide, Inc. (EEFT) common stock, totaling 2,214,718 shares. This information comes from a SCHEDULE 13G SEC filing, indicating that Bank of Montreal holds sole voting power over …